• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Disease and Therapy Review: Lung Cancer Product Image

Disease and Therapy Review: Lung Cancer

  • ID: 1195634
  • November 2012
  • Region: Global
  • 15 Pages
  • Timely Data Resources, Inc

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities.

Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.

The Lung Cancer Disease and Therapy Review provides an overview of small cell and non-small cell lung cancer, with incidence, prevalence, and mortality numbers for major countries worldwide, information on diagnosis, and an overview of treatment. General information on the lung cancer market, as well as sales of leading drugs and therapies are provided.

I. OVERVIEW
General description of the condition
Risk factors
SCLC description, staging and survival rates
NSCLC description, staging and survival rates

II. INCIDENCE, PREVALENCE AND MORTALITY
Incidence Table (Canada, U.S., Argentina, Brazil, Mexico, France, Germany, Greece, Italy, Poland, Russian Federation, Spain, Turkey, UK, China, India, Japan, Philippines, Thailand, Egypt, South Africa, Africa, Americas, Eastern Mediterranean, Europe, Southeast Asia, Western Pacific, Worldwide)
Prevalence Table (Canada, U.S., Argentina, Brazil, Mexico, France, Germany, Greece, Italy, Poland, Russian Federation, Spain, Sweden, Turkey, UK, China, India, Japan, Korea, Philippines, Thailand, Egypt, South Africa, Africa, Americas. Eastern Mediterranean, Europe, Southeast Asia, Western Pacific, More Developed, Less Developed, Worldwide)

Mortality Table (Canada, U.S., Argentina, Brazil, Mexico, France, Germany, Greece, Italy, Poland, Russian Federation, Spain, Turkey, UK, China, India, Japan, Philippines, Thailand, Egypt, South Africa, Australia, Africa, Americas, Eastern Mediterranean, Europe, European Union, Southeast Asia, Western Pacific, Worldwide)

III. DIAGNOSIS
Symptoms and signs
Diagnostic tools and procedure

IV. TREAMENT
SCLC treatment
NSCLC treatment, including treatment options by stage and chemotherapy

V. MARKET SIZE
Market overview
Sales information for key pharmaceuticals

VI. COMMENTS

VII. REFERENCES/RESOURCES

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos